Skip to main content
SpringerLink
Log in

A Potential Role for PTEN in the Diabetic Heart

  • Short Communication
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kondo T, Kahn CR. Altered insulin signaling in retinal tissue in diabetic states. J Biol Chem 2004;279(36):37997–8006.

    Article  PubMed  CAS  Google Scholar 

  2. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004;61(3):448–60.

    Article  PubMed  CAS  Google Scholar 

  3. Hlobilkova A, Knillova J, Bartek J, Lukas J, Kolar Z. The mechanism of action of the tumour suppressor gene PTEN. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003;147(1):19–25.

    PubMed  CAS  Google Scholar 

  4. Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, Backx PH. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 2004;37(2):449–71.

    Article  PubMed  CAS  Google Scholar 

  5. Cai Z, Semenza GL. PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning. Circ Res 2005;97(12):1351–9.

    Article  PubMed  CAS  Google Scholar 

  6. Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM. Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes 2005;54(8):2360–4.

    PubMed  CAS  Google Scholar 

  7. Mensah K, Mocanu MM, Yellon DM. Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? J Am Coll Cardiol 2005;45(8):1287–91.

    Article  PubMed  CAS  Google Scholar 

  8. Teresi RE, Shaiu CW, Chen CS, Chatterjee VK, Waite KA, Eng C. Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone. Int J Cancer 2006;118(10):2390–8.

    Article  PubMed  CAS  Google Scholar 

  9. Butler M, McKay RA, Popoff IJ, et al. Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 2002;51(4):1028–34.

    PubMed  CAS  Google Scholar 

  10. Kushner JA, Simpson L, Wartschow LM, et al. Phosphatase and tensin homolog regulation of islet growth and glucose homeostasis. J Biol Chem 2005;280(47):39388–93.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Hatter Cardiovascular Institute, University College London Hospital and Medical School, Chenies Mew, London, WC1E 6HX, UK

    Mihaela M. Mocanu, Duncan C. Field & Derek M. Yellon

Authors
  1. Mihaela M. Mocanu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Duncan C. Field
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Derek M. Yellon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Derek M. Yellon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mocanu, M.M., Field, D.C. & Yellon, D.M. A Potential Role for PTEN in the Diabetic Heart. Cardiovasc Drugs Ther 20, 319–321 (2006). https://doi.org/10.1007/s10557-006-8876-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-006-8876-4

Key words

Search

Navigation